4.8 Review

Type I Interferons in the Pathogenesis of Tuberculosis: Molecular Drivers and Immunological Consequences

Journal

FRONTIERS IN IMMUNOLOGY
Volume 8, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2017.01633

Keywords

Mycobacterium tuberculosis; type I interferon; innate immune signaling; pattern recognition receptors; immune responses; cytokines; patients; mouse models

Categories

Funding

  1. National Health and Medical Research Council of Australia [GNT1120230]
  2. University of Queensland Diamantina Institute
  3. University of Queensland

Ask authors/readers for more resources

Tuberculosis (TB) remains a major global health threat. Urgent needs in the fight against TB include improved and innovative treatment options for drug-sensitive and -resistant TB as well as reliable biological indicators that discriminate active from latent disease and enable monitoring of treatment success or failure. Prominent interferon (IFN) inducible gene signatures in TB patients and animal models of Mycobacterium tuberculosis infection have drawn significant attention to the roles of type I IFNs in the host response to mycobacterial infections. Here, we review recent developments in the understanding of the innate immune pathways that drive type I IFN responses in mycobacteria-infected host cells and the functional consequences for the host defense against M. tuberculosis, with a view that such insights might be exploited for the development of targeted host-directed immunotherapies and development of reliable biomarkers.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

PI3K-p110δ contributes to antibody responses by macrophages in chronic lymphocytic leukemia

Yu-Chen Enya Chen, Melinda Burgess, Sally Mapp, Peter Mollee, Devinder Gill, Antje Blumenthal, Nicholas A. Saunders

LEUKEMIA (2020)

Article Cell Biology

Class IIa Histone Deacetylases Drive Toll-like Receptor-Inducible Glycolysis and Macrophage Inflammatory Responses via Pyruvate Kinase M2

Kaustav Das Gupta, Melanie R. Shakespear, James E. B. Curson, Ambika M. V. Murthy, Abishek Iyer, Mark P. Hodson, Divya Ramnath, Vikas A. Tillu, Jessica B. von Pein, Robert C. Reid, Kathryn Tunny, Daniel M. Hohenhaus, Shayli Varasteh Moradi, Gregory M. Kelly, Takumi Kobayashi, Jennifer H. Gunter, Alexander J. Stevenson, Weijun Xu, Lin Luo, Alun Jones, Wayne A. Johnston, Antje Blumenthal, Kirill Alexandrov, Brett M. Collins, Jennifer L. Stow, David P. Fairlie, Matthew J. Sweet

CELL REPORTS (2020)

Review Chemistry, Medicinal

Pexidartinib, a Novel Small Molecule CSF-1R Inhibitor in Use for Tenosynovial Giant Cell Tumor: A Systematic Review of Pre-Clinical and Clinical Development

Brooke Benner, Logan Good, Dionisia Quiroga, Thomas E. Schultz, Mahmoud Kassem, William E. Carson, Mathew A. Cherian, Sagar Sardesai, Robert Wesolowski

DRUG DESIGN DEVELOPMENT AND THERAPY (2020)

Article Chemistry, Organic

Lincolnenins A-D: Isomeric Bactericidal Bianthracenes from Streptomyces lincolnensis

Osama G. Mohamed, Zeinab G. Khalil, Angela A. Salim, Hui Cui, Antje Blumenthal, Robert J. Capon

Summary: Cultivation profiling of Streptomyces lincolnensis led to the discovery of four new isomeric bianthracenes, lincolnenins A-D, with relative stereostructures determined by detailed spectroscopic analysis. Lincolnenins A and B exhibit restricted rotation, while C and D are thermally interconvertible atropisomers. Lincolnenin A showed significant bactericidal activity against various drug-resistant Gram-positive pathogens.

JOURNAL OF ORGANIC CHEMISTRY (2021)

Review Microbiology

Microbiome-immune interactions in tuberculosis

Giorgia Mori, Mark Morrison, Antje Blumenthal

Summary: This article discusses the impact of the microbiota on tuberculosis susceptibility, manifestation, and progression, as well as its potential as a target for clinical manipulation.

PLOS PATHOGENS (2021)

Article Cell Biology

Rab6b localizes to the Golgi complex in murine macrophages and promotes tumor necrosis factor release in response to mycobacterial infection

Leslie C. Domi'nguez Cadena, Thomas E. Schultz, Alina Zamoshnikova, Meg L. Donovan, Carmen D. Mathmann, Chien-Hsiung Yu, Giorgia Mori, Jennifer L. Stow, Antje Blumenthal

Summary: The study demonstrates that Rab6b plays a positive regulatory role in promoting TNF release induced by M. bovis BCG infection in macrophages, localized to the Golgi complex. These findings help to elucidate the molecular mechanisms of Rab6b in regulating inflammatory cytokine responses in macrophages.

IMMUNOLOGY AND CELL BIOLOGY (2021)

Article Immunology

Pre-Diabetes Increases Tuberculosis Disease Severity, While High Body Fat Without Impaired Glucose Tolerance Is Protective

Roma Sinha, Minh Dao Ngo, Stacey Bartlett, Helle Bielefeldt-Ohmann, Sahar Keshvari, Sumaira Z. Hasnain, Meg L. Donovan, Jessica C. Kling, Antje Blumenthal, Chen Chen, Kirsty R. Short, Katharina Ronacher

Summary: This study found that pre-diabetes increases susceptibility to TB, while a high body mass index without dysglycemia is protective. The murine model established in this study provides an opportunity to further study the underlying immunological, metabolic, and endocrine mechanisms of this association.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)

Article Oncology

Weekly vs. 3-weekly paclitaxel, carboplatin, and cetuximab (PCC) in recurrent/metastatic head and neck cancer

Leeann Geraghty, Thomas E. Schultz, Sarah E. Hoffman, Kyle Porter, Majd Issa, Vidhya Karivedu, Marcelo Bonomi

Summary: The study found that weekly PCC had a lower risk of G3/4 toxicity and better overall efficacy compared to PCC administered every 3 weeks in patients with recurrent/metastatic squamous cell carcinoma of the head and neck.

MOLECULAR AND CLINICAL ONCOLOGY (2021)

Article Multidisciplinary Sciences

Neutrophil extracellular traps and their histones promote Th17 cell differentiation directly via TLR2

Alicia S. Wilson, Katrina L. Randall, Jessica A. Pettitt, Julia Ellyard, Antje Blumenthal, Anselm Enders, Benjamin J. Quah, Tobias Bopp, Christopher R. Parish, Anne Bruestle

Summary: This study reveals the mechanism by which neutrophil extracellular traps (NETs) directly activate T cells and specifically enhance Th17 cell differentiation. This suggests a direct link between neutrophils, NETs, and T cell autoimmunity.

NATURE COMMUNICATIONS (2022)

Article Immunology

Distinct contributions of the innate immune receptors TLR2 and RP105 to formation and architecture of structured lung granulomas in mice infected with Mycobacterium tuberculosis

Meg L. Donovan, Helle Bielefeldt-Ohmann, Rachel F. Rollo, Stephen J. McPherson, Thomas E. Schultz, Giorgia Mori, Jessica C. Kling, Antje Blumenthal

Summary: In this study, the researchers used a mouse model to investigate the role of TLR2 and RP105 in the formation and architecture of tuberculosis granulomas. They found that TLR2 and RP105 play important roles in controlling the extent and spatial positioning of lung pathology in tuberculosis infection. The researchers also observed that TLR2 and RP105 have different functions in different strains of Mycobacterium tuberculosis. This study highlights the significance of TLRs as molecular determinants of tuberculosis granuloma formation and architecture.

IMMUNOLOGY (2023)

Article Health Care Sciences & Services

Nitric Oxide on Extracorporeal Membrane Oxygenation in Neonates and Children (NECTAR Trial): Protocol for a Randomized Controlled Trial

Adrian C. Mattke, Kerry Johnson, Kristen Gibbons, Debbie Long, Jeremy Robertson, Prem S. Venugopal, Antje Blumenthal, Andreas Schibler, Luregn Schlapbach

Summary: This article describes a study on the feasibility and safety of mixing nitric oxide (NO) into extracorporeal membrane oxygenation (ECMO) systems. The study aims to assess the impact of NO on inflammation and coagulation system activation during ECMO support. The goal is to improve outcomes for children receiving ECMO treatment.

JMIR RESEARCH PROTOCOLS (2023)

Article Microbiology

Wollamide Cyclic Hexapeptides Synergize with Established and New Tuberculosis Antibiotics in Targeting Mycobacterium tuberculosis

Rachel F. Rollo, Giorgia Mori, Timothy A. Hill, Doris Hillemann, Stefan Niemann, Susanne Homolka, David P. Fairlie, Antje Blumenthal

Summary: Shorter and more effective treatment regimens as well as new drugs are urgently needed to reduce the global burden of tuberculosis (TB). This study discovered a new compound called wollamide B1, which has antimycobacterial activity and can synergize with existing TB antibiotics, enhancing their effectiveness. Wollamide B1 also remains effective against drug-resistant TB strains.

MICROBIOLOGY SPECTRUM (2023)

No Data Available